These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653 [TBL] [Abstract][Full Text] [Related]
44. [Clinical experience with the preparation 39089-Ba in some arrhythmias]. Sodi Pallares D Arch Inst Cardiol Mex; 1968; 38(5):707-13. PubMed ID: 4178512 [No Abstract] [Full Text] [Related]
45. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias]. Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360 [TBL] [Abstract][Full Text] [Related]
47. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy]. Rosenbaum M; Posse R; Sgammini H; Núñez Burgos J; Chiale PA; Pastori JD; González Zuelgaray J; Brunetto JF; Califano JE Arch Inst Cardiol Mex; 1987; 57(4):325-30. PubMed ID: 2445316 [TBL] [Abstract][Full Text] [Related]
48. [Cordarone in the maintenance of sinus rhythm: prevention of paroxysmal atrial fibrillation and of supraventricular paroxysmal tachycardia]. Zagatti G; Benzoni A; Caturelli G Arch Maragliano Patol Clin; 1974; 30(2):245-9. PubMed ID: 4480711 [No Abstract] [Full Text] [Related]
49. [Clinical experiences in the use of amiodarone in the suppression of ventricular premature contractions]. Chang HM; Hwang YS; Wang JL; Lai HM Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Sep; 3(9):584-90. PubMed ID: 2455068 [No Abstract] [Full Text] [Related]
51. [Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias]. Ricevuti A; Bianchi C; Bonifazi C; Coppetti S; Ferrari O; Rinaldo R; Rizzi M; Tavecchi L; Zampaglione G; Ziletti G; Distante S G Ital Cardiol; 1981; 11(6):812-9. PubMed ID: 7319187 [TBL] [Abstract][Full Text] [Related]
52. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366. Baum T; Rowles G; Shropshire AT J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546 [No Abstract] [Full Text] [Related]
53. [Arrhythmias in childhood. Tachycardiac rhythms]. Marsico F; Musto B; Greco R G Ital Cardiol; 1976; 6(4):732-41. PubMed ID: 61900 [No Abstract] [Full Text] [Related]
54. [Therapy of arrhythmias]. Hartl O; Clodi PH Wien Z Inn Med; 1973; 54(8-9):384-98. PubMed ID: 4139823 [No Abstract] [Full Text] [Related]
55. Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction. Remme WJ; van Hoogenhuyze DC Cardioscience; 1990 Sep; 1(3):169-76. PubMed ID: 2102806 [TBL] [Abstract][Full Text] [Related]
56. [What is safe in the therapy of tachycardic heart arrhythmias?]. Wehr M; Noll B; Krappe J Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980 [No Abstract] [Full Text] [Related]
58. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias. Schmidt A; König W; Binner L; Mayer U; Stauch M Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512 [TBL] [Abstract][Full Text] [Related]
59. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias. Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579 [TBL] [Abstract][Full Text] [Related]
60. Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials. Cadrin-Tourigny J; Wyse DG; Roy D; Blondeau L; Levesque S; Talajic M; Andrade JG; Dubuc M; Thibault B; Guerra PG; Macle L; Rivard L; Khairy P J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1306-13. PubMed ID: 25181386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]